Transition From Alendronate to Romosozumab (AMG 785)
Clinical trial NCT01588509 · COMPLETED
Trial details
- NCT number
- NCT01588509
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-30
- Primary completion
- 2012-11-21
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.